Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine in aluminium phosphide poisoning
IRCT20211221053473N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of thiamine in Aluminium phosphide poisoning (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Vomiting, Abdominal pain and 13 more. Started Jan 2021; status: completed.
02
Drugs
thiamine
03
Conditions
Aluminium phosphide poisoning
Beyond the preview
Go deeper on IRCT20211221053473N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211221053473N1.